Latest Market Research Updates

Respiratory Disease Testing Market Is Predicted To Reach $6.7 Billion By 2025

The global respiratory diseases testing market is expected to reach USD 6.7 billion by 2025, according to a new report by Grand View Research, Inc. The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than 200 million people across the globe suffered from Chronic Obstructive Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In addition, the source stated that more than 50 million people struggle with occupational lung diseases annually. Thus, constantly growing target patient population is anticipated to drive the growth.

The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring. Airway management plays a main role in the testing and management of COPD. Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the market.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/respiratory-disease-testing-market

Further key findings from the study suggest:

The growing prevalence of COPD and asthma across the globe is expected to increase the demand for respiratory disease testing devices and thereby drive the market growth
In products, imaging tests held the largest share in 2016 due to rapid development and adoption of innovative technologies
In respiratory measurement, spirometers, pulse oximeters, ventilators, capnographs, and other noninvasive ventilators used for measurement of lung capacity are expected to grow at a rate of more than 4% over the forecast period
In end-use, hospitals segment held the largest share in 2016 and is anticipated to grow over the forecast period
North America the largest market share in 2016. Growing prevalence of respiratory diseases such as COPD, asthma is increasing the demand for respiratory disease testing/diagnostic in North American countries.
Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors such as improving health care infrastructure and increasing patient awareness regarding the availability of new diagnostic techniques for respiratory diseases, such as COPD & asthma.
Some of the major players competing in this market include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company; Fischer & Paykel; and Medtronic. These players are strong brands in the market as they have elaborate product portfolios in respiratory disease testing market.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Cell Culture Protein Surface Coating Market Is Poised To Reach $1.3 Billion By 2025

The global cell culture protein surface coating market is expected to reach a value of USD 1.3 billion by 2025, according to a new report by Grand View Research, Inc. Increasing focus on stem cell research and development is the most substantial factor that drives the market growth during the forecast period. Stem cell therapy is the most promising method to treat severe medical conditions such as cardiovascular disease, brain disease, cell deficiency therapy, and blood disease. Thus, the biotechnology companies and research laboratories are adopting innovative protein surface coating products for the development of stem cells.

Rising demand for biopharmaceutical products including antibodies, vaccines, proteins, and drugs is another major factor driving the growth of the cell culture protein surface coating market. The production of biopharmaceutical products such as monoclonal antibodies and recombinant proteins is carried out by using cell culture technique. The protein surface coating provides improved adhesion and proliferation of cells in vitro. Thus, the demand of cell culture protein surface coating is growing at a high rate, which is estimated to drive the growth of this sector.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/cell-culture-protein-surface-coating-market

Further key findings from the study suggest:

Self-coating was the largest revenue grossing segment of the cell culture protein surface coatingmarket in 2015. It is expected to uphold its dominance during the forecast period owing to its large application in 2D and 3D cell cultures
The precoated product segment is the fastest growing segment due to growing popularity of multiwell/microwell plates for in vitro applications
The synthetic protein segment is anticipated to grow at the fastest rate during forecast period, due to its advantages over other protein types such as reduced risk of contamination and simplified composition
North America was the largest revenue-generating region of the market in the year 2015. This region is expected to maintain its position during the forecast period
Existence of big biopharmaceutical companies and highly developed healthcare infrastructure is projected to drive the demand for products of the target market in the region during forecast period
Asia Pacific region is anticipated to be the fastest growing segment over the forecast period
Rapidly booming biotechnology industry and comparatively less stringent regulations for biologics development in APAC region is primarily driving the growth of this sector
Some of the key players include Corning Inc.; Merck KGaA; Thermo Fisher Scientific, Inc.; Greiner Bio One International GmbH; PerkinElmer, Inc.; BioVision, Inc.; and Trevigen Inc.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Wearable Injectors Market Is Poised To Reach $11.3 Billion By 2025

The global wearable injectors market is anticipated to reach USD 11.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period owing to technological advancements in wearable injectors coupled with rising demand for round-the-clock monitoring. The paradigm shift towards self-administration of injectable is expected to drive the market during the forecast period. In addition, increasing awareness and rising adoption of wearable injectors are expected to assist in growth.

Technological advancements in wearable injectors, such as Bluetooth integrated wearable injectors, enable sending alerts to patients, such as injection reminders, and provide patients access to data regarding their therapy regime. Also, optional smart functionality provides connectivity to the healthcare network. Some of these devices have buttons that are accessible through clothing, and others prevent accidental activation. They also have audio and visual status indicators or signals. Patients can self-administer drugs subcutaneously in less time and with minimal effort as compared to intravenous or other routes. Patients are not required to visit any healthcare provider for administration.

Prevalence of lifestyle-associated diseases, such as diabetes and hypertension, is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters, such as blood pressure and blood sugar levels. Thus, integration of healthcare data with wearable injectors, which gets forwarded to physicians or doctors giving them real-time access with minimal errors, is expected to boost the wearable injectors market.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/wearable-injectors-market

Further Key Findings From the Study Suggest:

The on-body segment held lucrative market share in 2016, owing to growing preference of patients for adhesive patches that release the drug easily and can be worn on the skin
The motor-driven segment is expected to register the highest growth over the forecast period owing to increasing demand from hospitals, clinics, retail chain stores, and pharmacies
The oncology segment is expected to gain the largest market share due to increasing incidence of cancer worldwide
North America is expected to dominate the wearable injectors market over the forecast period due to rising demand for innovative Information Technology (IT) solutions to streamline workflow and increasing regulatory requirements to ensure patient safety
Some of the key players in wearable injectors market are Becton, Dickinson and Company; Johnson & Johnson Services, Inc.; F. Hoffmann-La Roche Ltd.; Unilife Corporation; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet Corporation; Enable Injections; West Pharmaceutical Services, Inc.; and CeQur SA.

About Grand View Research

Pressure Monitoring Market Is Predicted To Reach $11.9 Billion By 2025

The global pressure monitoring market is expected to reach USD 11.9 billion by 2025, according to a new report by Grand View Research, Inc. Pressure fluctuations in vital parts of the body often lead to chronic diseases such as glaucoma, cardiac disorders, and respiratory disorders. This has led to high demand for pressure monitoring devices.

According to the American Heart Association, 77.9 million people were suffering from hypertension in the U.S. in 2014. Patients suffering from lifestyle diseases like cardiac disorders are likely to experience hypertension throughout their life. Hence, there is a growing need for pressure monitoring amongst such kind of patients, thereby, increasing the demand for pressure monitoring devices.

Rising geriatric population is another significant driver stimulating the growth of pressure monitoring market. Aging population commonly suffer from hypertension and are highly susceptible to chronic diseases. This age group that experiences cardiac and respiratory diseases are expected to contribute toward high growth of pressure monitoring market in the near future.

Technological advancements are also spurring in the market due to the introduction of novel pressure monitoring devices. Many products are connected to smartphones so that people can self-monitor their blood pressure with ease. In addition, key players are manufacturing devices that measure intraocular pressure in order to reduce the risk of glaucoma.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/pressure-monitoring-market

Further key findings from the study suggest:

In 2016, blood pressure monitoring devices dominated the market owing to rising prevalence of hypertension and heart-related disorders
Amongst the procedure segment, noninvasive technique held the largest share in 2016 due to wide usage of noninvasive blood pressure monitors
Cardiac disorders accounted for the largest share in 2016 due to growing prevalence of heart diseases causing blood pressure fluctuations
In 2016, hospitals generated the largest revenue due to its growing usage of invasive as well as noninvasive pressure monitoring devices
North America dominated the market in 2016 owing to rising prevalence of cardiac diseases and hypertension in the U.S.
Asia Pacific is expected to showcase lucrative CAGR over the forecast period owing to rising geriatric population in China
Some of the major players include Philips Healthcare; Medtronic; GE Healthcare; Drägerwerk AG & Co. KGaA; Becton, Dickinson and Company; Welch Allyn; and NIHON KOHDEN CORPORATION.

About Grand View Research

Pulse Oximeters Market Worth Scope $2.8 Billion By 2025

The global pulse oximeters market size is expected to reach USD 2.8 billion by 2025, based on a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.3% during the forecast period. The growth can be attributed to high prevalence of target diseases, such as Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, cardiac arrhythmia, and ischemic conditions. Pulse oximetry is mandatory for newborn screening in almost 43 states in the U.S. It is also gaining roots in other parts of the world as it helps in detection of Congenital Heart Defect (CHD).

Technological advancements in pulse oximeters to make the devices more efficient and user-friendly can boost the demand. For instance, in August 2015, Nonin Medical, Inc. launched NoninConnect Model 3230, a wireless fingertip oximeter that can be operated via Bluetooth. The product has low power usage and was intended for the identification of early intervention patients with respiratory conditions, such as COPD.

Asia Pacific is anticipated to register the fastest growth over the forthcoming years. Increasing investments from industry players is the key driver for the regional growth. In January 2017, Masimo launched two patient monitoring products in India, namely, Rad-97 Pulse-CO Oximeter and SedLine Brain Function Monitoring. These products are expected to improve the patient monitoring capabilities of clinicians in the region.

Product innovation and R&D are some of the major strategies adopted by the key companies operating in the market for pulse oximeters. For instance, in September 2018, Masimo announced the FDA approval of rainbow Acoustic Monitoring RAS-45 Sensor, a noninvasive respiration rate measurement system for infant and neonatal patients. In July 2018, the company launched the Vital Signs Check Application— a comprehensive patient data collection application for the Masimo Root patient connectivity and monitoring platform.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/pulse-oximeter-market

Further key findings from the study suggest:

Handheld segment led the market in 2018, attributed to the rising number of surgeries and emphasis on patient safety during anesthesia. These devices are preferred for long-term monitoring in hospitals and emergency rooms
Fingertip oximeters is the most lucrative segment. The ease of use and easy availability across stores, such as Wal-Mart and CVS is the key reason for the growing popularity of these devices
The hospitals and other healthcare facilities segment led the end use segment in 2018 and is expected to maintain its dominance during the forecast period, due to the presence of a large patient base and growing use of vital stats monitoring devices
North America held the largest market share in 2018 and is expected to maintain its position during the forecast period. The mandatory CCHD screening for newborns imposed by the Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics (AAP) in September 2014 is one of the major drivers
Some of the key players operating in the pulse oximeters market are Covidien; CareFusion Corp; GE Healthcare; Koninklijke Philips N.V.; Masimo; CAS Medical Systems, Inc.; Opto Circuits India Ltd.; Nonin Medical, Inc.; Smiths Medical; Welch Allyn; Spacelabs Healthcare; Zensorium; Meditech Equipment Co. Ltd.; and Nihon Kohden Corporation.

About Grand View Research

Pharma Logistics Market Is Predicted To Beat $97.6 Billion By 2025

The global pharmaceutical logistics market size is anticipated to reach USD 97.6 billion by 2025 expanding at a CAGR of 3.5%, according to a new report by Grand View Research, Inc. The market development can be attributed to the rising demand for a variety of drugs as a result of increasing cases of chronic and lifestyle-related diseases. Pharmaceutical logistics is an important part of the healthcare system, as careful handling and transporting of pharmaceutical products is of utmost importance, therefore equipment and staff services involved in the pharma supply chain are highly expensive.

Consolidations among the pharma companies, to expand their business and global presence, is the latest trend gaining momentum in the market. Technological advancements, such as cloud-based supply chain functions and blockchain technology, which provide accurate and real-time data of operations will also have a positive impact on the pharma logistics market growth. Additionally, these technologies also offer predictive analytics to identify demand and supply chain optimization and risk management. Identifying risk and preventing them helps companies increase productivity, efficiency, and process optimization of their businesses.

The North America regional market accounted for the largest market share in 2018 and is expected to maintain its dominance over the forecast period. The market in Asia Pacific is projected to exhibit the highest CAGR from 2019 to 2025 owing to increasing financial budget for the healthcare sector in several emerging countries of the region. Some of the key market participants include FedEx Corp.; DB Schenker; Deutsche Post DHL; Air Canada Cargo; United Parcel Service of America, Inc.; CEVA Logistics; Continental Air Cargo; and Biotec Services International Ltd.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/pharmaceutical-logistics-market

Further key findings from the study suggest:

Logistics led the global market in 2018 and is expected to be the dominant segment even during the forecast period
This growth can be attributed to the increased adoption of sea freight pharma logistics, which handles personalized medicines
North American is expected to be the largest regional market over the next few years owing to the rising M&A activity in the region
Prominent companies in the global pharmaceutical logistics market include FedEx Corp.; DB Schenker; Deutsche Post DHL; United Parcel Service of America, Inc.; CEVA Logistics; Continental Air Cargo; Biotec Services International Ltd.; and Air Canada Cargo

About Grand View Research

Antifungal Drugs Market Size Worth Would Be $12.7 Billion By 2025

San Francisco, 24 Oct 2019 - The global antifungal drugs market size is expected to reach USD 12.7 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 1.5% during the forecast period. Increasing incidence of fungal infections worldwide is the key factor stoking the growth of the market. In addition, rise in adoption of immunosuppressive and antineoplastic agents, prosthetic devices and grafts, and broad-spectrum antibiotics has resulted in increased incidence of fungal infections in recent years.

According to statistics published by the Centers of Disease Control and Prevention in 2017, it has been estimated that every year, nearly 220,000 new individuals are affected by cryptococcal meningitis, which is a brain infection and has resulted in 181,000 deaths per year around the world. Most of the deaths were reported in sub-Saharan Africa, due to high prevalence of HIV/AIDS. This indicates the potential demand for antifungal drugs due to high prevalence of mycological infections around the globe.

As aged people are more prone to infectious diseases and chronic conditions, including HIV and cancer, rise in geriatric population worldwide is likely to stir up the demand for antifungals to treat opportunistic fungal infections. The demand for fungistatic agents is estimated to remain strong through 2025 due to mounting cases of fungal infections that are difficult to diagnose, yielding high mortality and morbidity rates.

Access Full Insight: https://www.grandviewresearch.com/industry-analysis/antifungal-drugs-market

Further key findings from the study suggest:

Several types of fungicidal preparations, such as creams, sprays, tablets, & injections, are available. Increasing adoption of these products is anticipated to drive the market during the forecast period
The echinocandins segment is anticipated to exhibit lucrative growth owing to their cell wall-specific fungicidal property coupled with their broad-spectrum activity against Aspergillusand Candida species without cross-resistance risks
The candidiasis indication segment is expected to witness the fastest CAGR over the forecast period due to increasing drug resistance of the Candida species to Azoles
North America held the largest market share in 2017. The growth of the market can be attributed to higher awareness levels pertaining to treatment of fungal infection and presence of a large target population
Asia pacific is projected to register the fastest growth during the forecast period due to improving healthcare facilities coupled with rising government initiatives to create awareness of infectious diseases among the population
Companies are focusing on development of effective therapeutic agents for treatment of systemic fungal infections in immune-compromised patients
Numerous ongoing public-private partnership agreements in the pharmaceutical industry for development of novel therapeutics is poised to provide the market with lucrative growth opportunities. For instance, Astellas Pharma partnered with Vical Incorporated for the development of VL-2397, an antifungal drug for the treatment of pulmonary aspergillus.

About Grand View Research

Latest Market Research Updates

Respiratory Disease Testing Market Is Predicted To Reach $6.7 Billion By 2025

Cell Culture Protein Surface Coating Market Is Poised To Reach $1.3 Billion By 2025

Wearable Injectors Market Is Poised To Reach $11.3 Billion By 2025

Pressure Monitoring Market Is Predicted To Reach $11.9 Billion By 2025

Pulse Oximeters Market Worth Scope $2.8 Billion By 2025

Pharma Logistics Market Is Predicted To Beat $97.6 Billion By 2025

Antifungal Drugs Market Size Worth Would Be $12.7 Billion By 2025

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

Report Abuse

Labels